Expertise in Renal Research
Each year, DaVita Inc. treats approximately one-third of the total US end-stage renal disease (ESRD) patient population – about 188,000 patients receiving dialysis — and more than 90,000 patients with chronic kidney disease (CKD). As a wholly-owned subsidiary of DaVita Inc., DaVita Clinical Research (DCR) can access comprehensive patient-level data to guide the design of your protocol, identify sites and quickly identify subjects for potential enrollment into late phase (Phase II-IV) clinical trials.
Our team has a 15-year track record of advancing kidney care and clinical trials, and brings exceptional depth of knowledge and clinical expertise. We employ a resourceful approach to late phase clinical trials in order to help you make confident decisions and meet your late phase study timelines. View DCR’s Late Phase capabilities at a glance!
What to expect with DCR® as your Late Phase Partner
- DaVita Patient Data & Site Metrics
DCR’s unique data-driven feasibility process requires higher-level resources and utilizes real-world data and site knowledge to deliver a differentiated product.
- DaVita Principal Investigator Pool
DCR has long-standing relationships with over 150 DaVita principal investigators with longitudinal metrics on sites regarding trial performance. View our Featured CKD Investigators here.
- DaVita Feasibility & Enrollment Forecast
DCR leverages the electronic medical record (EMR) data where possible to provide principal investigators with patient-level identified lists to enable enrollment and forecasting for the study.
- DaVita Screening Targets
Our targets are set based on the feasibility and electronic medical record (EMR) data. We seek to consistently meet or exceed those targets on each and every study we contract.
- DaVita & CRO Site Start up/Activation
We focus on performance. Our average time to IRB approval per site is 30 days. Our average time to CTA execution is 23 days per site.
- DaVita Site Management Enrollment
Our project managers are an extension of your study team. The longstanding relationships with our nephrology partners is often the best tool to identify root cause issues that we can then work together to solve.
- DaVita Drives Site Performance Execution
A deep dive conversation into the inclusion/exclusion criteria, logistical nuances, and potential roadblocks is held between the DCR® team and the site in order to drive site performance.
Our ability to quickly identify potential qualified patient participants and our long-standing relationships with investigator physicians allows for rapid study start-up using data-driven metrics to select appropriate sites for late phase clinical studies. No other clinical research organization has deeper experience in conducting renal trials. DaVita Clinical Research has helped develop every end stage renal drug receiving FDA approval in the past 15 years. Contact our Late Phase clinical research team to find out more.